These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2979272)

  • 1. A double-blind placebo-controlled trial of BRL 24924 on lower oesophageal sphincter pressure and gastro-oesophageal reflux in healthy volunteers.
    Robertson CS; Evans DF; Hicks F; Atkinson M
    Aliment Pharmacol Ther; 1988 Dec; 2(6):501-6. PubMed ID: 2979272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind dose ranging study of BRL 24924 and metoclopramide on lower oesophageal sphincter pressure in healthy volunteers.
    Robertson CS; Ledingham SJ; Cooper SM; Evans DF
    Br J Clin Pharmacol; 1989 Sep; 28(3):323-7. PubMed ID: 2789926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
    Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R
    Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease.
    van Herwaarden MA; Samsom M; Rydholm H; Smout AJ
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1655-62. PubMed ID: 12197845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of non-selective gamma-aminobutyric acid receptor stimulation on motor function of the lower oesophageal sphincter and gastro-oesophageal reflux in healthy human subjects.
    Cantù P; Carmagnola S; Savojardo D; Allocca M; Penagini R
    Aliment Pharmacol Ther; 2003 Oct; 18(7):699-704. PubMed ID: 14510743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.
    Wienbeck M; Li Q
    Scand J Gastroenterol Suppl; 1989; 165():13-8; discussion 27-8. PubMed ID: 2690320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of a 5-HT3 antagonist, pancopride, on lower oesophageal sphincter pressure in volunteers.
    Grande L; Lacima G; Pérez A; Zayas JM
    Br J Clin Pharmacol; 1995 Oct; 40(4):401-3. PubMed ID: 8554943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease.
    Trudgill NJ; Hussain FN; Moustafa M; Ajjan R; D'Amato M; Riley SA
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1357-64. PubMed ID: 11552906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease.
    Finizia C; Lundell L; Cange L; Ruth M
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):9-14. PubMed ID: 11782569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of caloric density of a meal on lower oesophageal sphincter motility and gastro-oesophageal reflux in healthy subjects.
    Pehl C; Pfeiffer A; Waizenhoefer A; Wendl B; Schepp W
    Aliment Pharmacol Ther; 2001 Feb; 15(2):233-9. PubMed ID: 11148443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.
    Kahrilas PJ; Quigley EM; Castell DO; Spechler SJ
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1503-9. PubMed ID: 11069322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.
    Zhang Q; Lehmann A; Rigda R; Dent J; Holloway RH
    Gut; 2002 Jan; 50(1):19-24. PubMed ID: 11772961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of baclofen on lower oesophageal sphincter pressure and proximal gastric motility in humans.
    Lee KJ; Vos R; Janssens J; Tack J
    Aliment Pharmacol Ther; 2003 Jul; 18(2):199-207. PubMed ID: 12869080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?
    Hirsch DP; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2002 Jan; 16(1):17-26. PubMed ID: 11856074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cisapride on postprandial gastro-oesophageal reflux.
    Holloway RH; Downton J; Mitchell B; Dent J
    Gut; 1989 Sep; 30(9):1187-93. PubMed ID: 2680794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
    Ramirez B; Richter JE
    Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.
    Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM
    Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.